{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:53:35Z","timestamp":1761807215786},"reference-count":115,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1053\/pb.2000.6692","type":"journal-article","created":{"date-parts":[[2006,5,26]],"date-time":"2006-05-26T00:06:56Z","timestamp":1148602016000},"page":"108-117","source":"Crossref","is-referenced-by-count":14,"title":["Neurology of systemic autoimmune disorders: A pediatric perspective"],"prefix":"10.1053","volume":"7","author":[{"given":"Nina Felice","family":"Schor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/pb.2000.6692_bib1","first-page":"579","article-title":"Management of collagen vascular diseases in childhood","volume":"16","author":"DeSilva","year":"1998","journal-title":"Pediatr Dermatol"},{"key":"10.1053\/pb.2000.6692_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-510X(96)00238-9","article-title":"Systemic lupus erythematosus with multiple perivascular spongy changes in the cerebral deep structures, midbrain and cerebellar white matter: A case report","volume":"145","author":"Matsumoto","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1053\/pb.2000.6692_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF02021529","article-title":"MRI changes in the central nervous system in a child with lupus erythematosus","volume":"25","author":"Gieron","year":"1995","journal-title":"Pediatr Radiol"},{"key":"10.1053\/pb.2000.6692_bib4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0003-9993(98)90150-2","article-title":"Three women with lupus transverse myelitis: case reports and differential diagnosis","volume":"79","author":"Inslicht","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1053\/pb.2000.6692_bib5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0033-3182(95)71644-9","article-title":"Neuropsychiatric manifestations of systemic lupus erythematosus","volume":"36","author":"Calabrese","year":"1995","journal-title":"Psychosomatics"},{"key":"10.1053\/pb.2000.6692_bib6","first-page":"284","article-title":"Hyperintense basal ganglia on T1-weighted MR images in a patient with central nervous system lupus and chorea","volume":"19","author":"Kashihara","year":"1998","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1053\/pb.2000.6692_bib7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archneur.1988.00520340015003","article-title":"Headaches in patients with systemic lupus erythematosus: Clinical and telethermographic findings","volume":"45","author":"Anzola","year":"1988","journal-title":"Arch Neurol"},{"issue":"suppl 16","key":"10.1053\/pb.2000.6692_bib8","first-page":"S23","article-title":"International survey on the management of patients with SLE. II: The results of a questionnaire regarding neuropsychiatric manifestations","volume":"14","author":"Tincani","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib9","first-page":"1112","article-title":"Technitium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement","volume":"38","author":"Lin","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1053\/pb.2000.6692_bib10","first-page":"1271","article-title":"Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy","volume":"18","author":"Sibbitt","year":"1997","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1053\/pb.2000.6692_bib11","first-page":"232","article-title":"Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus","volume":"10","author":"Glanz","year":"1997","journal-title":"Neuropsychiatr Neuropsychol Behavioral Neurol"},{"key":"10.1053\/pb.2000.6692_bib12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI: A disease activity index for lupus patients","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pb.2000.6692_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1529-0131(199801)41:1<41::AID-ART6>3.0.CO;2-7","article-title":"Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease","volume":"41","author":"Kozora","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pb.2000.6692_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/art.1780400107","article-title":"Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus","volume":"40","author":"Chinn","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pb.2000.6692_bib15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/rheumatology\/34.11.1055","article-title":"Magnetic resonance imaging of the brain in systemic lupus erythematosus","volume":"34","author":"Gonzalez-Crespo","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib16","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/art.1780380615","article-title":"Spin-spin relaxation of brain tissues in systemic lupus erythematosus: A method for increasing the sensitivity of magnetic resonance imaging for neuropsychiatric lupus","volume":"38","author":"Sibbitt","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pb.2000.6692_bib17","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2214\/ajr.167.6.8956600","article-title":"Patients with antiphospholipid antibodies: CT and MR findings of the brain","volume":"167","author":"Provenzale","year":"1996","journal-title":"AJR Am J Roentgenology"},{"key":"10.1053\/pb.2000.6692_bib18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0049-0172(79)80009-8","article-title":"Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955\u20131977","volume":"8","author":"Ellis","year":"1979","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/pb.2000.6692_bib19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00604798","article-title":"MRI and angiographic diagnosis of lupus cerebral vasculitis","volume":"38","author":"Liem","year":"1996","journal-title":"Neuroradiology"},{"key":"10.1053\/pb.2000.6692_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1749-6632.1997.tb48389.x","article-title":"MRI-MRS of the brain in systemic lupus erythematosus: How do we use it to understand causes of clinical signs?","volume":"823","author":"Tanabe","year":"1997","journal-title":"Ann NY Acad Sci"},{"key":"10.1053\/pb.2000.6692_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.1997.tb48385.x","article-title":"Detection of cerebral ischemia in systemic lupus erythematosus by magnetic resonance techniques","volume":"823","author":"Welch","year":"1997","journal-title":"Ann NY Acad Sci"},{"key":"10.1053\/pb.2000.6692_bib22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/art.1780330609","article-title":"Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy","volume":"33","author":"Griffey","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pb.2000.6692_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s004150050071","article-title":"Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus","volume":"244","author":"Sailer","year":"1997","journal-title":"J Neurol"},{"key":"10.1053\/pb.2000.6692_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0887-8994(97)00074-X","article-title":"Serial single photon emission computed tomography imaging in patients with cerebral lupus during acute exacerbation and after treatment","volume":"17","author":"Huang","year":"1997","journal-title":"Pediatr Neurol"},{"key":"10.1053\/pb.2000.6692_bib25","first-page":"787","article-title":"Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: A controlled positron emission tomography study","volume":"24","author":"Otte","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/pb.2000.6692_bib26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/BF00808421","article-title":"18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus","volume":"22","author":"Gr\u00fcnwald","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/pb.2000.6692_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00997243","article-title":"Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: Relations with EEG and MRI findings and clinical manifestations","volume":"22","author":"Colamussi","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/pb.2000.6692_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00006231-199703000-00012","article-title":"Brain perfusion SPET and proton magnetic resonance imaging spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations","volume":"18","author":"Colamussi","year":"1997","journal-title":"Nucl Med Comm"},{"key":"10.1053\/pb.2000.6692_bib29","first-page":"1247","article-title":"The use of single photon emission computerized tomography in neuropsychiatric SLE: A pilot study","volume":"22","author":"Kovacs","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-1759(12)80052-4","article-title":"Detection of brain reactive autoantibody in sera of autoimmune mice using ELISA","volume":"149","author":"Crimando","year":"1992","journal-title":"J Immunol Methods"},{"key":"10.1053\/pb.2000.6692_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-1759(95)00133-U","article-title":"Detection of brain-reactive autoantibodies in the sera of patients with systemic lupus erythematosus and cerebral involvement","volume":"185","author":"Ochola","year":"1995","journal-title":"J Immunol Methods"},{"key":"10.1053\/pb.2000.6692_bib32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jnnp.58.5.548","article-title":"Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Beh\u00e7et's disease involving the nervous system","volume":"58","author":"McLean","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/pb.2000.6692_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0002-9343(99)80135-1","article-title":"Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests","volume":"99","author":"West","year":"1995","journal-title":"Am J Med"},{"key":"10.1053\/pb.2000.6692_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-5728(97)00157-4","article-title":"Identification and cloning of a brain autoantigen in neuro-behavioral SLE","volume":"82","author":"Moore","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1053\/pb.2000.6692_bib35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1749-6632.1997.tb48395.x","article-title":"Central interleukin-1 receptors as mediators of sickness","volume":"823","author":"Kelley","year":"1997","journal-title":"Ann NY Acad Sci USA"},{"key":"10.1053\/pb.2000.6692_bib36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0002-9343(70)80006-7","article-title":"The epidemiology of polymyositis","volume":"48","author":"Medsger","year":"1970","journal-title":"Am J Med"},{"key":"10.1053\/pb.2000.6692_bib37","first-page":"1329","article-title":"Incidence of polymyositis-dermatomyositis: A 20 year study of hospital diagnosed cases in Allegheny County, PA, 1963\u201382","volume":"17","author":"Oddis","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib38","first-page":"197","article-title":"Epidemiology of polymyositis-dermatomyositis in Israel, 1960\u201376","volume":"16","author":"Benbassat","year":"1980","journal-title":"Isr J Med Sci"},{"key":"10.1053\/pb.2000.6692_bib39","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/34.8.732","article-title":"The incidence of juvenile dermatomyositis: Results from a nation-wide study","volume":"34","author":"Symmons","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib40","first-page":"1198","article-title":"Juvenile dermatomyositis at diagnosis: Clinical characteristics of 79 children","volume":"25","author":"Pachman","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00002281-199509000-00013","article-title":"An update on juvenile dermatomyositis","volume":"7","author":"Pachman","year":"1995","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1742-1241.1996.tb10042.x","article-title":"Juvenile dermatomyositis associated with partial lipodystrophy","volume":"50","author":"Huang","year":"1996","journal-title":"Br J Clin Pract"},{"key":"10.1053\/pb.2000.6692_bib43","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/rheumatology\/36.8.917","article-title":"Palmar plantar hyperkeratosis-a previously undescribed skin manifestation of juvenile dermatomyositis","volume":"36","author":"See","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1542\/peds.100.3.391","article-title":"Juvenile dermatomyositis presenting with rash alone","volume":"100","author":"Eisenstein","year":"1997","journal-title":"Pediatrics"},{"key":"10.1053\/pb.2000.6692_bib45","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/archderm.1995.01690240124023","article-title":"Amyopathic dermatomyositis","volume":"131","author":"Kagen","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1053\/pb.2000.6692_bib46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1365-2133.1997.d01-1217.x","article-title":"Juvenile amyopathic dermatomyositis","volume":"136","author":"Hess Schmid","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1053\/pb.2000.6692_bib47","first-page":"1369","article-title":"Polyneuropathy in juvenile dermatomyositis","volume":"22","author":"Vogelgesang","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib48","first-page":"531","article-title":"Systemic vasculitis in juvenile dermatomyositis: A fatal case","volume":"13","author":"Falcini","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib49","first-page":"473","article-title":"Muscle strength assessment in polymyositis and dermatomyositis evaluation of the reliability and clinical use of a new, quantitative, easily applicable method","volume":"22","author":"Stoll","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib50","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/archderm.1995.01690170022003","article-title":"Phosphorus 31 magnetic resonance spectroscopy for quantitative evaluation of therapeutic regimens in dermatomyositis","volume":"131","author":"King","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1053\/pb.2000.6692_bib51","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0733-8619(05)70337-6","article-title":"Idiopathic inflammatory myopathies","volume":"15","author":"Amato","year":"1997","journal-title":"Neurol Clin"},{"key":"10.1053\/pb.2000.6692_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00878536","article-title":"Automatic decomposition electromyography in idiopathic inflammatory myopathies","volume":"243","author":"Jongen","year":"1996","journal-title":"J Neurol"},{"key":"10.1053\/pb.2000.6692_bib53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/art.1790100308","article-title":"Inflammatory myopathies: Issues in diagnosis and management","volume":"10","author":"Olsen","year":"1997","journal-title":"Arthritis Care and Research"},{"key":"10.1053\/pb.2000.6692_bib54","first-page":"4","article-title":"MRS and NIRS for muscle disease evaluation","volume":"44","author":"Olsen","year":"1995","journal-title":"Bull Rheum Dis"},{"key":"10.1053\/pb.2000.6692_bib55","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archneur.55.7.987","article-title":"Antimyosin scintigraphy compared with magnetic resonance imaging in inflammatory myopathies","volume":"55","author":"Lofberg","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1053\/pb.2000.6692_bib56","first-page":"326","article-title":"Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire","volume":"22","author":"Feldman","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib57","first-page":"320","article-title":"Von Willebrand Factor in juvenile dermatomyositis","volume":"22","author":"Bloom","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib58","first-page":"193","article-title":"Imperfect indications of disease activity in juvenile dermatomyositis","volume":"22","author":"Pachman","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib59","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1212\/WNL.46.5.1445","article-title":"Elevated serum levels of manganese superoxide dismutase in polymyositis and dermatomyositis","volume":"46","author":"Mokuno","year":"1996","journal-title":"Neurology"},{"key":"10.1053\/pb.2000.6692_bib60","first-page":"357","article-title":"Anti-Jo-1 antibodies in polymyositis or dermatomyositis: Evaluation by ELISA using recombinant fusion protein Jo-1 as antigen","volume":"37","author":"Nishikai","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1053\/pb.2000.6692_bib61","first-page":"1794","article-title":"Clinical significance of specific autoantibodies in juvenile dermatomyositis","volume":"23","author":"Feldman","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib62","first-page":"395","article-title":"Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis","volume":"25","author":"Roux","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib63","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/art.1780390218","article-title":"Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis","volume":"39","author":"Vazquez-Abad","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pb.2000.6692_bib64","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/art.1780390119","article-title":"Autoantibodies to glycyl-transfer RNA synthetase in myositis: Association with dermatomyositis and immunologic heterogeneity","volume":"39","author":"Hirakata","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pb.2000.6692_bib65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/art.1780380119","article-title":"Analysis of the Mi-2 autoantigen of dermatomyositis","volume":"38","author":"Nilasena","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pb.2000.6692_bib66","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/art.1780381006","article-title":"The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation","volume":"38","author":"Seelig","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pb.2000.6692_bib67","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/art.1780391029","article-title":"Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen","volume":"39","author":"Seelig","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pb.2000.6692_bib68","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1172\/JCI118218","article-title":"Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen","volume":"96","author":"Ge","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1053\/pb.2000.6692_bib69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0198-8859(95)00035-6","article-title":"Association of the HLA-DQA1*0501 allele in multiple racial groups with juvenile dermatomyositis","volume":"44","author":"Reed","year":"1995","journal-title":"Hum Immunol"},{"key":"10.1053\/pb.2000.6692_bib70","first-page":"1000","article-title":"Immunogenetic studies in families of children with juvenile dermatomyositis","volume":"25","author":"Reed","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib71","first-page":"1109","article-title":"Association of HLA class I and class II alleles with myositis in Japanese patients","volume":"25","author":"Furuya","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib72","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00005176-199707000-00018","article-title":"Concurrence of celiac disease and juvenile dermatomyositis: Result of a specific immunogenetic susceptibility?","volume":"25","author":"Buderus","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1053\/pb.2000.6692_bib73","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.4049\/jimmunol.159.12.6260","article-title":"Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ\u03b11*0501\/DQ\u03b21*0301 molecule","volume":"159","author":"Reed","year":"1997","journal-title":"J Immunol"},{"key":"10.1053\/pb.2000.6692_bib74","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00019052-199606000-00015","article-title":"The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis","volume":"9","author":"Dalakas","year":"1996","journal-title":"Curr Opin Neurol"},{"key":"10.1053\/pb.2000.6692_bib75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-5728(96)00133-6","article-title":"Increased in vitro uptake of the complement C3b in the serum of patients with Guillain-Barr\u00e9 syndrome, myasthenia gravis and dermatomyositis","volume":"71","author":"Basta","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1053\/pb.2000.6692_bib76","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00019052-199606000-00014","article-title":"The immunopathogenic role of complement in human muscle disease","volume":"9","author":"Mendell","year":"1996","journal-title":"Curr Opin Neurol"},{"key":"10.1053\/pb.2000.6692_bib77","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00005072-199612000-00003","article-title":"MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: Studies in patients with polymyositis, dermatomyositis, and inclusion body myositis","volume":"55","author":"Schneider","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1053\/pb.2000.6692_bib78","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/clin.1998.4527","article-title":"Cell death and oxidative damage in inflammatory myopathies","volume":"87","author":"Tews","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1053\/pb.2000.6692_bib79","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/brain\/120.6.929","article-title":"Cytotoxic mechanisms in inflammatory myopathies: Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells","volume":"120","author":"Behrens","year":"1997","journal-title":"Brain"},{"key":"10.1053\/pb.2000.6692_bib80","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/088307389801300701","article-title":"Whimpers and bangs: of death and dying in the nervous system","volume":"13","author":"Schor","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1053\/pb.2000.6692_bib81","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/(SICI)1097-4598(199706)20:6<651::AID-MUS1>3.0.CO;2-7","article-title":"Treatment of inflammatory myopathies","volume":"20","author":"Mastaglia","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1053\/pb.2000.6692_bib82","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/088307389801300303","article-title":"Drug therapy in juvenile dermatomyositis: Follow-up study","volume":"13","author":"Ng","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1053\/pb.2000.6692_bib83","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-3476(96)70295-0","article-title":"Failure of pulse intravenous methylprednisone treatment in juvenile dermatomyositis","volume":"128","author":"Lang","year":"1996","journal-title":"J Pediatr"},{"key":"10.1053\/pb.2000.6692_bib84","first-page":"270","article-title":"Plasma exchange in polymyositis and dermatomyositis: A multi center study of 57 cases","volume":"13","author":"Cherin","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib85","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0887-8994(95)00195-6","article-title":"Treatment of childhood dermatomyositis with high dose intravenous immunoglobulin","volume":"13","author":"Vedanarayanan","year":"1995","journal-title":"Pediatr Neurol"},{"key":"10.1053\/pb.2000.6692_bib86","doi-asserted-by":"crossref","first-page":"70S","DOI":"10.1007\/BF01540896","article-title":"Update on the use intravenous immune globulin in the treatment of patients with inflammatory muscle disease","volume":"15","author":"Dalakas","year":"1995","journal-title":"J Clin Immunol"},{"key":"10.1053\/pb.2000.6692_bib87","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/adc.72.1.25","article-title":"Intravenous immunoglobulin in juvenile dermatomyositis-four year review of nine cases","volume":"72","author":"Sansome","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1053\/pb.2000.6692_bib88","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jnnp.65.1.107","article-title":"Immunoglobulin therapy in inflammatory myopathies","volume":"65","author":"Mastaglia","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/pb.2000.6692_bib89","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02230347","article-title":"Efficacy of intravenous immunoglobulin therapy in a case of juvenile dermatomyositis","volume":"15","author":"Galeazzi","year":"1996","journal-title":"Clin Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib90","first-page":"2152","article-title":"Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis","volume":"23","author":"Oliveri","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib91","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1210\/jc.82.11.3536","article-title":"Calcinosis universalis complicating juvenile dermatomyositis: Resolution during probenecid therapy","volume":"82","author":"Eddy","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/pb.2000.6692_bib92","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/rheumatology\/37.2.196","article-title":"Improvement of physical fitness and muscle strength in polymyositis\/dermatomyositis patients by a training programme","volume":"37","author":"Wiesinger","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib93","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00007611-199801000-00003","article-title":"Juvenile dermatomyositis and polymyositis: A follow-up study of long-term sequelae","volume":"91","author":"Collison","year":"1998","journal-title":"South Med J"},{"key":"10.1053\/pb.2000.6692_bib94","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/rheumatology\/35.8.725","article-title":"Anti-ganglioside antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy","volume":"35","author":"Salih","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib95","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/rheumatology\/35.11.1116","article-title":"Quantified neurological examination with emphasis on motor and sensory functions in patients with rheumatoid arthritis and controls","volume":"35","author":"Bekkelund","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib96","first-page":"253","article-title":"The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate","volume":"23","author":"Kaye","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib97","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1542\/peds.64.1.96","article-title":"Polyneuropathy in childhood","volume":"64","author":"Evans","year":"1979","journal-title":"Pediatrics"},{"key":"10.1053\/pb.2000.6692_bib98","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0404.1986.tb03256.x","article-title":"Nerve conduction velocities in juvenile rheumatoid arthritis","volume":"73","author":"Puusa","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"10.1053\/pb.2000.6692_bib99","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.64.3.382","article-title":"Behcet's syndrome: A report of 41 patients with emphasis on neurological manifestations","volume":"64","author":"Farah","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/pb.2000.6692_bib100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004150050205","article-title":"Behcet's disease and the nervous system","volume":"245","author":"Serdaroglu","year":"1998","journal-title":"J Neurol"},{"key":"10.1053\/pb.2000.6692_bib101","first-page":"502","article-title":"Juvenile Behcet's disease in Israel: The Pediatric Rheumatology Study Group of Israel","volume":"16","author":"Uziel","year":"1998","journal-title":"Clin Exper Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib102","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3928\/0191-3913-19980501-08","article-title":"Clinical features of pediatric Behcet's disease","volume":"35","author":"Eldem","year":"1998","journal-title":"J Pediat Ophthal Strabis"},{"key":"10.1053\/pb.2000.6692_bib103","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s004150050317","article-title":"Neuropsychological follow-up of 12 patients with neuro-Behcet disease","volume":"246","author":"Oktem-Tanor","year":"1999","journal-title":"J Neurol"},{"key":"10.1053\/pb.2000.6692_bib104","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1017\/S0317167100033552","article-title":"Parkinsonian syndrome as a neurological manifestation of Behcet's disease","volume":"25","author":"Bogdanova","year":"1998","journal-title":"Can J Neurol Sci"},{"key":"10.1053\/pb.2000.6692_bib105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-5347(01)62060-3","article-title":"Bladder involvement in Behcet's syndrome","volume":"161","author":"Cetinel","year":"1999","journal-title":"J Urol"},{"key":"10.1053\/pb.2000.6692_bib106","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/(SICI)1097-4598(199903)22:3<430::AID-MUS28>3.0.CO;2-#","article-title":"Muscular necrotizing vasculitis as the initial manifestation of Behcet's disease","volume":"22","author":"Kazarians","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1053\/pb.2000.6692_bib107","first-page":"1707","article-title":"Technicium-99m-HMPAO SPECT and MRI of brain in patients with neuro-Behcet's syndrome","volume":"39","author":"Kao","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/pb.2000.6692_bib108","first-page":"950","article-title":"Technicium-99m-HMPAO brain SPECT in Behcet's disease","volume":"39","author":"Garcia-Burillo","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/pb.2000.6692_bib109","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01450966","article-title":"Cerebral bloodflow abnormalities detected by SPECT in Behcet's syndrome-related psychiatric disorders","volume":"17","author":"Mirone","year":"1998","journal-title":"Clin Rheumatol"},{"key":"10.1053\/pb.2000.6692_bib110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-510X(98)00165-8","article-title":"Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease","volume":"159","author":"Hirohata","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1053\/pb.2000.6692_bib111","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2249.1998.00620.x","article-title":"Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behcet patients","volume":"113","author":"Tasci","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/pb.2000.6692_bib112","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1365-4362.1998.00114.x","article-title":"Protien C and protein S activities in Behcet's disease as risk factors of thrombosis","volume":"37","author":"Lenk","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1053\/pb.2000.6692_bib113","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005792-198207000-00004","article-title":"Neurologic complications of primary Sjogren's syndrome","volume":"61","author":"Alexander","year":"1982","journal-title":"Medicine"},{"key":"10.1053\/pb.2000.6692_bib114","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0002-9343(81)90194-7","article-title":"Neurologic manifestations of systemic vasculitis: A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients","volume":"71","author":"Moore","year":"1981","journal-title":"Am J Med"},{"key":"10.1053\/pb.2000.6692_bib115","first-page":"459","article-title":"Vasculitic neuropathy: Profile of twenty patients","volume":"43","author":"Singhal","year":"1995","journal-title":"J Assoc Physicians India"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909100800169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909100800169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T14:11:50Z","timestamp":1683468710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909100800169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S1071909100800169"],"URL":"https:\/\/doi.org\/10.1053\/pb.2000.6692","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}